We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

340B Program: U.S. District Court for the District of Columbia Vacates HRSA's Final Rule on the 340B Orphan Drug Exclusion

Christopher H. Schott

Christopher H. Schott,

Washington, D.C.

Alice Valder Curran

Natalie Morris

02 June 2014
On Friday, May 23, 2014, the U.S. District Court for the District of Columbia "vacated," or invalidated, the Health Resources and Services Administration's (HRSA) final rule on the treatment of orphan drugs under the 340B Drug Discount Program. HRSA, which administers the 340B program, released the final rule in July 2013.
Christopher H. Schott

Christopher H. Schott,

Washington, D.C.

Alice Valder Curran

Natalie Morris

Loading data